Literature DB >> 12600429

Surgical and patient reported outcomes of 'clam' augmentation ileocystoplasty in spinal cord injured patients.

J Khastgir1, R Hamid, M Arya, N Shah, P J R Shah.   

Abstract

OBJECTIVE: To study the outcomes and effectiveness of 'clam' augmentation ileocystoplasty in the treatment of suprasacral spinal cord injured patients with detrusor hyperreflexia refractory to pharmacological and other conservative therapy.
METHODS: A retrospective review of spinal injured patients who had undergone 'clam' augmentation ileocystoplasty was performed, followed by a specifically designed questionnaire/telephone interview to assess patient satisfaction and other issues from this specific group of patients with suprasacral spinal cord lesions. 32 patients were followed up for a mean of 6.0 +/- 3.6 years.
RESULTS: Complete continence was found in all patients. There was a significant improvement in bladder capacity from a mean 143 +/- 81 ml pre-operatively to 589 +/- 188 ml post-operatively, and the maximum detrusor pressure fell from a mean of 108 +/- 43 cm H(2)O to 19 +/- 15 cm H(2)O. Pre-operative vesico-ureteric reflux resolved completely in 4 out of 5 patients and improved from grade IV to grade II in one, illustrating the need for achieving low bladder pressures rather than the performance of an anti-reflux procedure at the time of cystoplasty. The use of the questionnaire, designed to evaluate this subset of patients after augmentation cystoplasty, highlighted the high levels of satisfaction with the operation in this group of patients with 96.2% of patients reporting an improvement in quality of life parameters.
CONCLUSION: Using an appropriate questionnaire we have found high satisfaction rates, in addition to successful surgical outcomes, in spinal cord injured patients following augmentation cystoplasty. We recommend using this questionnaire as part of the work-up and ongoing assessment of spinal injured patients undergoing 'clam' augmentation ileocystoplasty. Copyright 2003 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2003        PMID: 12600429     DOI: 10.1016/s0302-2838(03)00008-3

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

1.  Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers.

Authors: 
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 2.  Augmentation cystoplasty: what are the indications?

Authors:  Polina Reyblat; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

Review 3.  Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

Authors:  Evan Shreck; Kevin Gioia; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

4.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

5.  Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI.

Authors:  C Anquetil; S Abdelhamid; A Gelis; C Fattal
Journal:  Spinal Cord       Date:  2016-04-26       Impact factor: 2.772

6.  Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients.

Authors:  Polina Reyblat; Kevin G Chan; David Y Josephson; John P Stein; John A Freeman; Gary D Grossfeld; David Esrig; David A Ginsberg
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

7.  OnabotulinumtoxinA in the treatment of neurogenic bladder.

Authors:  Aziz Gulamhusein; Altaf Mangera
Journal:  Biologics       Date:  2012-08-28

Review 8.  Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

Authors:  Jonathan D Campbell; Katharine S Gries; Jonathan H Watanabe; Arliene Ravelo; Roger R Dmochowski; Sean D Sullivan
Journal:  BMC Urol       Date:  2009-11-20       Impact factor: 2.264

9.  Augmentation cystoplasty: Contemporary indications, techniques and complications.

Authors:  Rajan Veeratterapillay; Andrew C Thorpe; Chris Harding
Journal:  Indian J Urol       Date:  2013-10

Review 10.  Augmentation cystoplasty in neurogenic bladder.

Authors:  Bülent Çetinel; Ervin Kocjancic; Çetin Demirdağ
Journal:  Investig Clin Urol       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.